Neal Walker
2016
In 2016, Neal Walker earned a total compensation of $4.7M as President and Chief Executive Officer at Aclaris Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $273,000 |
|---|---|
| Option Awards | $3,261,440 |
| Salary | $420,000 |
| Stock Awards | $701,773 |
| Other | $11,096 |
| Total | $4,667,309 |
Walker received $3.3M in option awards, accounting for 70% of the total pay in 2016.
Walker also received $273K in non-equity incentive plan, $420K in salary, $701.8K in stock awards and $11.1K in other compensation.
Rankings
In 2016, Neal Walker's compensation ranked 1,787th out of 14,075 executives tracked by ExecPay. In other words, Walker earned more than 87.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,787 out of 14,075 | 87th |
Division Manufacturing | 606 out of 5,489 | 89th |
Major group Chemicals And Allied Products | 169 out of 1,895 | 91st |
Industry group Drugs | 118 out of 1,538 | 92nd |
Industry Pharmaceutical Preparations | 94 out of 1,176 | 92nd |
Source: SEC filing on April 21, 2017.
Walker's colleagues
We found two more compensation records of executives who worked with Neal Walker at Aclaris Therapeutics in 2016.